{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:39Z","timestamp":1786979619899,"version":"build-2736575974"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ20034"],"award-info":[{"award-number":["2022JJ20034"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40475"],"award-info":[{"award-number":["2021JJ40475"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Research Foundation of Education Bureau of Hunan Province","award":["22B0412"],"award-info":[{"award-number":["22B0412"]}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["202202074638"],"award-info":[{"award-number":["202202074638"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970177"],"award-info":[{"award-number":["31970177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101869"],"award-info":[{"award-number":["82101869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Research Foundation of Education Bureau of Hunan Province","award":["22A0318"],"award-info":[{"award-number":["22A0318"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00109-023-02345-0","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T18:01:18Z","timestamp":1688666478000},"page":"947-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections"],"prefix":"10.1007","volume":"101","author":[{"given":"Cui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-5520","authenticated-orcid":false,"given":"Aihua","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"issue":"7280","key":"2345_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463(7280):540\u2013544","journal-title":"Nature"},{"issue":"7293","key":"2345_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464(7293):1367\u20131370","journal-title":"Nature"},{"issue":"4","key":"2345_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20051615","volume":"203","author":"PG Fallon","year":"2006","unstructured":"Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR, McIlgorm A, Jolin HE, McKenzie AN (2006) Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 203(4):1105\u20131116","journal-title":"J Exp Med"},{"issue":"25","key":"2345_CR4","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.1003988107","volume":"107","author":"AE Price","year":"2010","unstructured":"Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107(25):11489\u201311494","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6263","key":"2345_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","volume":"350","author":"G Gasteiger","year":"2015","unstructured":"Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY (2015) Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350(6263):981\u2013985","journal-title":"Science"},{"issue":"1","key":"2345_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ni.3309","volume":"17","author":"K Moro","year":"2016","unstructured":"Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M, Fukunaga K, Asano K, Betsuyaku T, Koyasu S (2016) Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 17(1):76\u201386","journal-title":"Nat Immunol"},{"key":"2345_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877005","volume":"13","author":"L Matha","year":"2022","unstructured":"Matha L, Takei F, Martinez-Gonzalez I (2022) Tissue resident and migratory group 2 innate lymphoid cells. Front Immunol 13:877005","journal-title":"Front Immunol"},{"issue":"6371","key":"2345_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.aam5809","volume":"359","author":"Y Huang","year":"2018","unstructured":"Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, Usher N, Zhu J, Urban JF Jr, Paul WE et al (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359(6371):114\u2013119","journal-title":"Science"},{"key":"2345_CR9","doi-asserted-by":"crossref","unstructured":"Dutton EE, Gajdasik DW, Willis C, Fiancette R, Bishop EL, Camelo A, Sleeman MA, Coccia M, Didierlaurent AM, Tomura M et al (2019) Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations. Sci Immunol 4(35)","DOI":"10.1126\/sciimmunol.aau8082"},{"issue":"3","key":"2345_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","volume":"50","author":"MW Dahlgren","year":"2019","unstructured":"Dahlgren MW, Jones SW, Cautivo KM, Dubinin A, Ortiz-Carpena JF, Farhat S, Yu KS, Lee K, Wang C, Molofsky AV et al (2019) Adventitial stromal cells define group 2 innate lymphoid cell tissue niches. Immunity 50(3):707\u2013722, e706","journal-title":"Immunity"},{"issue":"4","key":"2345_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","volume":"37","author":"T Hoyler","year":"2012","unstructured":"Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, Diefenbach A (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37(4):634\u2013648","journal-title":"Immunity"},{"issue":"4","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mjosberg","year":"2012","unstructured":"Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37(4):649\u2013659","journal-title":"Immunity"},{"issue":"8","key":"2345_CR13","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1084\/jem.20172359","volume":"215","author":"AH Lei","year":"2018","unstructured":"Lei AH, Xiao Q, Liu GY, Shi K, Yang Q, Li X, Liu YF, Wang HK, Cai WP, Guan YJ et al (2018) ICAM-1 controls development and function of ILC2. J Exp Med 215(8):2157\u20132174","journal-title":"J Exp Med"},{"issue":"7","key":"2345_CR14","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/all.14196","volume":"75","author":"S Toki","year":"2020","unstructured":"Toki S, Goleniewska K, Zhang J, Zhou W, Newcomb DC, Zhou B, Kita H, Boyd KL, Peebles RS Jr (2020) TSLP and IL-33 reciprocally promote each other\u2019s lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation. Allergy 75(7):1606\u20131617","journal-title":"Allergy"},{"issue":"11","key":"2345_CR15","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1111\/all.14526","volume":"75","author":"H Hong","year":"2020","unstructured":"Hong H, Liao S, Chen F, Yang Q, Wang DY (2020) Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy 75(11):2794\u20132804","journal-title":"Allergy"},{"key":"2345_CR16","doi-asserted-by":"crossref","unstructured":"Herbert DR, Douglas B, Zullo K (2019) Group 2 innate lymphoid cells (ILC2): type 2 immunity and helminth immunity. Int J Mol Sci 20(9)","DOI":"10.3390\/ijms20092276"},{"issue":"1","key":"2345_CR17","doi-asserted-by":"publisher","first-page":"300060521105315","DOI":"10.1177\/03000605211053156","volume":"50","author":"J Jin","year":"2022","unstructured":"Jin J, Sunusi S, Lu H (2022) Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target. J Int Med Res 50(1):3000605211053156","journal-title":"J Int Med Res"},{"issue":"12","key":"2345_CR18","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s42255-022-00685-8","volume":"4","author":"L Zhou","year":"2022","unstructured":"Zhou L, Lin Q, Sonnenberg GF (2022) Metabolic control of innate lymphoid cells in health and disease. Nat Metab 4(12):1650\u20131659","journal-title":"Nat Metab"},{"issue":"7470","key":"2345_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang HE et al (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502(7470):245\u2013248","journal-title":"Nature"},{"issue":"6","key":"2345_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2007.07.017","volume":"19","author":"T Doherty","year":"2007","unstructured":"Doherty T, Broide D (2007) Cytokines and growth factors in airway remodeling in asthma. Curr Opin Immunol 19(6):676\u2013680","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2345_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12(11):1045\u20131054","journal-title":"Nat Immunol"},{"issue":"2","key":"2345_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","volume":"42","author":"DMW Zaiss","year":"2015","unstructured":"Zaiss DMW, Gause WC, Osborne LC, Artis D (2015) Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 42(2):216\u2013226","journal-title":"Immunity"},{"issue":"34","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","volume":"112","author":"LA Monticelli","year":"2015","unstructured":"Monticelli LA, Osborne LC, Noti M, Tran SV, Zaiss DM, Artis D (2015) IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci USA 112(34):10762\u201310767","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2345_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/imr.12706","volume":"286","author":"H Kabata","year":"2018","unstructured":"Kabata H, Moro K, Koyasu S (2018) The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev 286(1):37\u201352","journal-title":"Immunol Rev"},{"issue":"22","key":"2345_CR25","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1007\/s00018-019-03228-9","volume":"76","author":"A Lei","year":"2019","unstructured":"Lei A, Zhou J (2019) Cell-surface molecule-mediated cell-cell interactions in the regulation of ILC2-driven allergic inflammation. Cell Mol Life Sci 76(22):4503\u20134510","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2345_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/imm.13232","volume":"161","author":"A Lei","year":"2020","unstructured":"Lei A, He Y, Yang Q, Li X, Li R (2020) Role of myeloid cells in the regulation of group 2 innate lymphoid cell-mediated allergic inflammation. Immunology 161(1):18\u201324","journal-title":"Immunology"},{"issue":"927","key":"2345_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258\u2013267","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"1","key":"2345_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12101","volume":"255","author":"RK Durbin","year":"2013","unstructured":"Durbin RK, Kotenko SV, Durbin JE (2013) Interferon induction and function at the mucosal surface. Immunol Rev 255(1):25\u201339","journal-title":"Immunol Rev"},{"key":"2345_CR29","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Ashkar AA (2018) The dual nature of type I and type II interferons. Front Immunol 9:2061","journal-title":"Front Immunol"},{"key":"2345_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.11.022","volume":"132","author":"GA Hile","year":"2020","unstructured":"Hile GA, Gudjonsson JE, Kahlenberg JM (2020) The influence of interferon on healthy and diseased skin. Cytokine 132:154605","journal-title":"Cytokine"},{"issue":"9","key":"2345_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB (2018) IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol 18(9):545\u2013558","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2345_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS (2019) Shared and distinct functions of type I and type III interferons. Immunity 50(4):907\u2013923","journal-title":"Immunity"},{"issue":"4","key":"2345_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/mi.2015.110","volume":"9","author":"UM Zissler","year":"2016","unstructured":"Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, Dietz K, Regn M, Knapp B, Theis FJ et al (2016) Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways. Mucosal Immunol 9(4):917\u2013926","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2345_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaci.2022.10.011","volume":"151","author":"L Chopp","year":"2023","unstructured":"Chopp L, Redmond C, O\u2019Shea JJ, Schwartz DM (2023) From thymus to tissues and tumors: a review of T-cell biology. J Allergy Clin Immunol 151(1):81\u201397","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2345_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4049\/jimmunol.1000469","volume":"185","author":"JP Huber","year":"2010","unstructured":"Huber JP, Ramos HJ, Gill MA, Farrar JD (2010) Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185(2):813\u2013817","journal-title":"J Immunol"},{"issue":"12","key":"2345_CR36","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.4049\/jimmunol.1301908","volume":"192","author":"JP Huber","year":"2014","unstructured":"Huber JP, Gonzales-van Horn SR, Roybal KT, Gill MA, Farrar JD (2014) IFN-alpha suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J Immunol 192(12):5687\u20135694","journal-title":"J Immunol"},{"issue":"1","key":"2345_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ni.3308","volume":"17","author":"CU Duerr","year":"2016","unstructured":"Duerr CU, McCarthy CD, Mindt BC, Rubio M, Meli AP, Pothlichet J, Eva MM, Gauchat JF, Qureshi ST, Mazer BD et al (2016) Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol 17(1):65\u201375","journal-title":"Nat Immunol"},{"issue":"1","key":"2345_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","volume":"43","author":"AB Molofsky","year":"2015","unstructured":"Molofsky AB, Van Gool F, Liang HE, Van Dyken SJ, Nussbaum JC, Lee J, Bluestone JA, Locksley RM (2015) Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 43(1):161\u2013174","journal-title":"Immunity"},{"issue":"1","key":"2345_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imm.12537","volume":"147","author":"F Kudo","year":"2016","unstructured":"Kudo F, Ikutani M, Seki Y, Otsubo T, Kawamura YI, Dohi T, Oshima K, Hattori M, Nakae S, Takatsu K et al (2016) Interferon-gamma constrains cytokine production of group 2 innate lymphoid cells. Immunology 147(1):21\u201329","journal-title":"Immunology"},{"issue":"8","key":"2345_CR40","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4049\/jimmunol.1601830","volume":"198","author":"J Bi","year":"2017","unstructured":"Bi J, Cui L, Yu G, Yang X, Chen Y, Wan X (2017) NK cells alleviate lung inflammation by negatively regulating group 2 innate lymphoid cells. J Immunol 198(8):3336\u20133344","journal-title":"J Immunol"},{"issue":"3","key":"2345_CR41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jaci.2017.04.043","volume":"141","author":"H Maazi","year":"2018","unstructured":"Maazi H, Banie H, Aleman Muench GR, Patel N, Wang B, Sankaranarayanan I, Bhargava V, Sato T, Lewis G, Cesaroni M et al (2018) Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity. J Allergy Clin Immunol 141(3):893\u2013905, e896","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2345_CR42","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.bbi.2011.03.007","volume":"25","author":"CM Sweeney","year":"2011","unstructured":"Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH et al (2011) IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun 25(6):1170\u20131181","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2345_CR43","doi-asserted-by":"publisher","first-page":"REVIEWS3011","DOI":"10.1186\/gb-2002-3-8-reviews3011","volume":"3","author":"MA Armant","year":"2002","unstructured":"Armant MA, Fenton MJ (2002) Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 3(8):REVIEWS3011","journal-title":"Genome Biol"},{"issue":"4","key":"2345_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783\u2013801","journal-title":"Cell"},{"issue":"2","key":"2345_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.smim.2015.03.005","volume":"27","author":"EM Coccia","year":"2015","unstructured":"Coccia EM, Battistini A (2015) Early IFN type I response: learning from microbial evasion strategies. Semin Immunol 27(2):85\u2013101","journal-title":"Semin Immunol"},{"issue":"8","key":"2345_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M (2015) The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 15(8):471\u2013485","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2345_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/mi.2012.20","volume":"5","author":"V Lombardi","year":"2012","unstructured":"Lombardi V, Speak AO, Kerzerho J, Szely N, Akbari O (2012) CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol 5(4):432\u2013443","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2345_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20040035","volume":"200","author":"HJ de Heer","year":"2004","unstructured":"de Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, Willart MA, Hoogsteden HC, Lambrecht BN (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200(1):89\u201398","journal-title":"J Exp Med"},{"issue":"5","key":"2345_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41423-019-0333-y","volume":"17","author":"M Wu","year":"2020","unstructured":"Wu M, Gao L, He M, Liu H, Jiang H, Shi K, Shang R, Liu B, Gao S, Chen H et al (2020) Plasmacytoid dendritic cell deficiency in neonates enhances allergic airway inflammation via reduced production of IFN-\u03b1. Cell Mol Immunol 17(5):519\u2013532","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"2345_CR50","doi-asserted-by":"publisher","first-page":"e0236744","DOI":"10.1371\/journal.pone.0236744","volume":"15","author":"L She","year":"2020","unstructured":"She L, Alanazi HH, Yan L, Brooks EG, Dube PH, Xiang Y, Zhang F, Sun Y, Liu Y, Zhang X et al (2020) Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness. PLoS ONE 15(7):e0236744","journal-title":"PLoS ONE"},{"issue":"3","key":"2345_CR51","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jaci.2021.07.041","volume":"149","author":"R Tei","year":"2022","unstructured":"Tei R, Iijima K, Matsumoto K, Kobayashi T, Lama J, Jacobsen EA, Kita H (2022) TLR3-driven IFN-beta antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung. J Allergy Clin Immunol 149(3):1044\u20131059, e1045","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2345_CR52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375\u2013386","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2345_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","volume":"25","author":"AH van Boxel-Dezaire","year":"2006","unstructured":"van Boxel-Dezaire AH, Rani MR, Stark GR (2006) Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25(3):361\u2013372","journal-title":"Immunity"},{"issue":"1","key":"2345_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/imr.12001","volume":"250","author":"J Piehler","year":"2012","unstructured":"Piehler J, Thomas C, Garcia KC, Schreiber G (2012) Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev 250(1):317\u2013334","journal-title":"Immunol Rev"},{"issue":"9","key":"2345_CR55","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1084\/jem.20082874","volume":"206","author":"SM McWhirter","year":"2009","unstructured":"McWhirter SM, Barbalat R, Monroe KM, Fontana MF, Hyodo M, Joncker NT, Ishii KJ, Akira S, Colonna M, Chen ZJ et al (2009) A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med 206(9):1899\u20131911","journal-title":"J Exp Med"},{"key":"2345_CR56","doi-asserted-by":"publisher","first-page":"e06670","DOI":"10.7554\/eLife.06670","volume":"4","author":"SM Blaauboer","year":"2015","unstructured":"Blaauboer SM, Mansouri S, Tucker HR, Wang HL, Gabrielle VD, Jin L (2015) The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo. Elife 4:e06670","journal-title":"Elife"},{"key":"2345_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618807","volume":"12","author":"KJ Cavagnero","year":"2021","unstructured":"Cavagnero KJ, Badrani JH, Naji LH, Amadeo MB, Leng AS, Lacasa LD, Strohm AN, Renusch SR, Gasparian SS, Doherty TA (2021) Cyclic-di-GMP induces STING-dependent ILC2 to ILC1 shift during innate type 2 lung inflammation. Front Immunol 12:618807","journal-title":"Front Immunol"},{"issue":"6121","key":"2345_CR58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339(6121):786\u2013791","journal-title":"Science"},{"issue":"6121","key":"2345_CR59","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339(6121):826\u2013830","journal-title":"Science"},{"issue":"3","key":"2345_CR60","doi-asserted-by":"publisher","first-page":"e143509","DOI":"10.1172\/jci.insight.143509","volume":"6","author":"L She","year":"2021","unstructured":"She L, Barrera GD, Yan L, Alanazi HH, Brooks EG, Dube PH, Sun Y, Zan H, Chupp DP, Zhang N et al (2021) STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology. JCI Insight 6(3):e143509","journal-title":"JCI Insight"},{"issue":"3","key":"2345_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1189\/jlb.1211588","volume":"93","author":"O Sareila","year":"2013","unstructured":"Sareila O, Jaakkola N, Olofsson P, Kelkka T, Holmdahl R (2013) Identification of a region in p47phox\/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation. J Leukoc Biol 93(3):427\u2013435","journal-title":"J Leukoc Biol"},{"key":"2345_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783944","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Zhang W, Zhang J, Li X, Zhang F, Zhu W, Meng L, Holmdahl R, Lu S (2021) Ncf1 governs immune niches in the lung to mediate pulmonary inflammation in mice. Front Immunol 12:783944","journal-title":"Front Immunol"},{"issue":"3","key":"2345_CR63","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jaci.2019.03.008","volume":"144","author":"CL Thio","year":"2019","unstructured":"Thio CL, Lai AC, Chi PY, Webster G, Chang YJ (2019) Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity. J Allergy Clin Immunol 144(3):682\u2013697, e689","journal-title":"J Allergy Clin Immunol"},{"key":"2345_CR64","doi-asserted-by":"crossref","unstructured":"Holgado A, Liu Z, Aidarova A, Mueller C, Haegman M, Driege Y, Kreike M, Scott CL, Afonina IS, Beyaert R (2023) A20 is a master switch of IL-33 signalling in macrophages and determines IL-33-induced lung immunity. J Allergy Clin Immunol S0091-6749(23)00287-7","DOI":"10.1016\/j.jaci.2023.02.026"},{"issue":"10","key":"2345_CR65","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41577-019-0191-y","volume":"19","author":"A Toubal","year":"2019","unstructured":"Toubal A, Nel I, Lotersztajn S, Lehuen A (2019) Mucosal-associated invariant T cells and disease. Nat Rev Immunol 19(10):643\u2013657","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2345_CR66","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jaci.2019.12.891","volume":"145","author":"L Ye","year":"2020","unstructured":"Ye L, Pan J, Pasha MA, Shen X, D\u2019Souza SS, Fung ITH, Wang Y, Guo B, Tang DD, Yang Q (2020) Mucosal-associated invariant T cells restrict allergic airway inflammation. J Allergy Clin Immunol 145(5):1469\u20131473, e1464","journal-title":"J Allergy Clin Immunol"},{"key":"2345_CR67","doi-asserted-by":"publisher","first-page":"1005226","DOI":"10.3389\/fimmu.2022.1005226","volume":"13","author":"Y Shimizu","year":"2022","unstructured":"Shimizu Y, Horigane-Konakai Y, Ishii Y, Sugimoto C, Wakao H (2022) Mucosal-associated invariant T cells repress group 2 innate lymphoid cells in Alternaria alternata-induced model of allergic airway inflammation. Front Immunol 13:1005226","journal-title":"Front Immunol"},{"issue":"6","key":"2345_CR68","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.20041901","volume":"201","author":"PA Wark","year":"2005","unstructured":"Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201(6):937\u2013947","journal-title":"J Exp Med"},{"issue":"9","key":"2345_CR69","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm1462","volume":"12","author":"M Contoli","year":"2006","unstructured":"Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL et al (2006) Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12(9):1023\u20131026","journal-title":"Nat Med"},{"issue":"4","key":"2345_CR70","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mi.2012.118","volume":"6","author":"MR Edwards","year":"2013","unstructured":"Edwards MR, Regamey N, Vareille M, Kieninger E, Gupta A, Shoemark A, Saglani S, Sykes A, Macintyre J, Davies J et al (2013) Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 6(4):797\u2013806","journal-title":"Mucosal Immunol"},{"key":"2345_CR71","doi-asserted-by":"crossref","unstructured":"Schaub B, Lauener R, von Mutius E (2006) The many faces of the hygiene hypothesis. J Allergy Clin Immunol 117(5):969\u2013977; quiz 978","DOI":"10.1016\/j.jaci.2006.03.003"},{"issue":"3","key":"2345_CR72","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/cea.13508","volume":"50","author":"V Pivniouk","year":"2020","unstructured":"Pivniouk V, Gimenes Junior JA, Honeker LK, Vercelli D (2020) The role of innate immunity in asthma development and protection: lessons from the environment. Clin Exp Allergy 50(3):282\u2013290","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"2345_CR73","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1365-2222.2000.00799.x","volume":"30","author":"J Riedler","year":"2000","unstructured":"Riedler J, Eder W, Oberfeld G, Schreuer M (2000) Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 30(2):194\u2013200","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"2345_CR74","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nri2871","volume":"10","author":"E von Mutius","year":"2010","unstructured":"von Mutius E, Vercelli D (2010) Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 10(12):861\u2013868","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2345_CR75","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJM200008243430803","volume":"343","author":"TM Ball","year":"2000","unstructured":"Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL (2000) Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 343(8):538\u2013543","journal-title":"N Engl J Med"},{"issue":"4","key":"2345_CR76","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2222.2008.03156.x","volume":"39","author":"YM Sjogren","year":"2009","unstructured":"Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E (2009) Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 39(4):518\u2013526","journal-title":"Clin Exp Allergy"},{"key":"2345_CR77","doi-asserted-by":"crossref","unstructured":"Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Muller G, Stokholm J, Smith B, Krogfelt KA (2011) Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 128(3):646\u2013652, e641\u2013645","DOI":"10.1016\/j.jaci.2011.04.060"},{"issue":"3","key":"2345_CR78","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1542\/peds.2008-1146","volume":"123","author":"F Marra","year":"2009","unstructured":"Marra F, Marra CA, Richardson K, Lynd LD, Kozyrskyj A, Patrick DM, Bowie WR, Fitzgerald JM (2009) Antibiotic use in children is associated with increased risk of asthma. Pediatrics 123(3):1003\u20131010","journal-title":"Pediatrics"},{"issue":"2","key":"2345_CR79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10753-022-01748-4","volume":"46","author":"Q Xiang","year":"2023","unstructured":"Xiang Q, Yan X, Lin X, Zheng H, Wang L, Wan J, Zhao W, Zhang W (2023) Intestinal microflora altered by vancomycin exposure in early life up-regulates type 2 innate lymphocyte and aggravates airway inflammation in asthmatic mice. Inflammation 46(2):509\u2013521","journal-title":"Inflammation"},{"issue":"3","key":"2345_CR80","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jaci.2021.09.013","volume":"149","author":"V Pivniouk","year":"2022","unstructured":"Pivniouk V, Gimenes-Junior JA, Ezeh P, Michael A, Pivniouk O, Hahn S, VanLinden SR, Malone SP, Abidov A, Anderson D et al (2022) Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium\/IL-33\/ILC2 axis. J Allergy Clin Immunol 149(3):943\u2013956","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2345_CR81","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41590-022-01350-8","volume":"23","author":"KE Block","year":"2022","unstructured":"Block KE, Iijima K, Pierson MJ, Walsh DA, Tei R, Kucaba TA, Xu J, Khan MH, Staley C, Griffith TS et al (2022) Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens. Nat Immunol 23(12):1703\u20131713","journal-title":"Nat Immunol"},{"issue":"2","key":"2345_CR82","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.immuni.2021.12.014","volume":"55","author":"KM Cautivo","year":"2022","unstructured":"Cautivo KM, Matatia PR, Lizama CO, Mroz NM, Dahlgren MW, Yu X, Sbierski-Kind J, Taruselli MT, Brooks JF, Wade-Vallance A et al (2022) Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity 55(2):254\u2013271, e257","journal-title":"Immunity"},{"issue":"5","key":"2345_CR83","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4049\/jimmunol.2100651","volume":"210","author":"J Dow","year":"2023","unstructured":"Dow J, Cytlak UM, Casulli J, McEntee CP, Smedley C, Hodge SH, D\u2019Elia RV, Hepworth MR, Travis MA (2023) Group 2 innate lymphoid cells are detrimental to the control of infection with Francisella tularensis. J Immunol 210(5):618\u2013627","journal-title":"J Immunol"},{"issue":"2","key":"2345_CR84","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.immuni.2022.01.007","volume":"55","author":"U Smole","year":"2022","unstructured":"Smole U, Hammad H (2022) IFN-gamma(g)uarding the niche-Keeping ILC2 in check. Immunity 55(2):190\u2013192","journal-title":"Immunity"},{"issue":"7","key":"2345_CR85","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrmicro2801","volume":"10","author":"MR Edwards","year":"2012","unstructured":"Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL (2012) The microbiology of asthma. Nat Rev Microbiol 10(7):459\u2013471","journal-title":"Nat Rev Microbiol"},{"issue":"19","key":"2345_CR86","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1359-6446(04)03239-8","volume":"9","author":"M Weinberger","year":"2004","unstructured":"Weinberger M (2004) Respiratory infections and asthma: current treatment strategies. Drug Discov Today 9(19):831\u2013837","journal-title":"Drug Discov Today"},{"key":"2345_CR87","doi-asserted-by":"crossref","unstructured":"Kreger JE, Hershenson MB (2022) Effects of COVID-19 and social distancing on rhinovirus infections and asthma exacerbations. Viruses 14(11)","DOI":"10.3390\/v14112340"},{"issue":"1","key":"2345_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00281-020-00781-5","volume":"42","author":"T Jartti","year":"2020","unstructured":"Jartti T, Bonnelykke K, Elenius V, Feleszko W (2020) Role of viruses in asthma. Semin Immunopathol 42(1):61\u201374","journal-title":"Semin Immunopathol"},{"issue":"4","key":"2345_CR89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1398-9995.2010.02505.x","volume":"66","author":"NG Papadopoulos","year":"2011","unstructured":"Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, Bonini S, Bont L, Bossios A, Bousquet J et al (2011) Viruses and bacteria in acute asthma exacerbations\u2013a GA(2) LEN-DARE systematic review. Allergy 66(4):458\u2013468","journal-title":"Allergy"},{"issue":"8","key":"2345_CR90","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/pai.12318","volume":"25","author":"R Turunen","year":"2014","unstructured":"Turunen R, Koistinen A, Vuorinen T, Arku B, Soderlund-Venermo M, Ruuskanen O, Jartti T (2014) The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol 25(8):796\u2013803","journal-title":"Pediatr Allergy Immunol"},{"key":"2345_CR91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2017.07.017","volume":"48","author":"HA Farne","year":"2017","unstructured":"Farne HA, Johnston SL (2017) Immune mechanisms of respiratory viral infections in asthma. Curr Opin Immunol 48:31\u201337","journal-title":"Curr Opin Immunol"},{"key":"2345_CR92","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fimmu.2018.01249","volume":"9","author":"KH Restori","year":"2018","unstructured":"Restori KH, Srinivasa BT, Ward BJ, Fixman ED (2018) Neonatal immunity, respiratory virus infections, and the development of asthma. Front Immunol 9:1249","journal-title":"Front Immunol"},{"issue":"1","key":"2345_CR93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","volume":"16","author":"VN Petrova","year":"2018","unstructured":"Petrova VN, Russell CA (2018) The evolution of seasonal influenza viruses. Nat Rev Microbiol 16(1):47\u201360","journal-title":"Nat Rev Microbiol"},{"key":"2345_CR94","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL (2018) Host immune response to influenza A virus infection. Front Immunol 9:320","journal-title":"Front Immunol"},{"issue":"1","key":"2345_CR95","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.antiviral.2010.07.006","volume":"88","author":"JK Yoo","year":"2010","unstructured":"Yoo JK, Baker DP, Fish EN (2010) Interferon-beta modulates type 1 immunity during influenza virus infection. Antiviral Res 88(1):64\u201371","journal-title":"Antiviral Res"},{"issue":"7","key":"2345_CR96","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ni.2045","volume":"12","author":"YJ Chang","year":"2011","unstructured":"Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12(7):631\u2013638","journal-title":"Nat Immunol"},{"issue":"9","key":"2345_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003615","volume":"9","author":"SA Gorski","year":"2013","unstructured":"Gorski SA, Hahn YS, Braciale TJ (2013) Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog 9(9):e1003615","journal-title":"PLoS Pathog"},{"issue":"8","key":"2345_CR98","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/pai.12462","volume":"26","author":"DH Shim","year":"2015","unstructured":"Shim DH, Park YA, Kim MJ, Hong JY, Baek JY, Kim KW, Byun YH, Seong BL, Ryu S, Song MK et al (2015) Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cells. Pediatr Allergy Immunol 26(8):780\u2013788","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2345_CR99","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/eji.201747421","volume":"49","author":"BWS Li","year":"2019","unstructured":"Li BWS, de Bruijn MJW, Lukkes M, van Nimwegen M, Bergen IM, KleinJan A, GeurtsvanKessel CH, Andeweg A, Rimmelzwaan GF, Hendriks RW (2019) T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice. Eur J Immunol 49(1):144\u2013156","journal-title":"Eur J Immunol"},{"issue":"22","key":"2345_CR100","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00598-21","volume":"95","author":"CM Williams","year":"2021","unstructured":"Williams CM, Roy S, Califano D, McKenzie ANJ, Metzger DW, Furuya Y (2021) The interleukin-33-group 2 innate lymphoid cell axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine. J Virol 95(22):e0059821","journal-title":"J Virol"},{"issue":"67","key":"2345_CR101","doi-asserted-by":"publisher","first-page":"eabc9934","DOI":"10.1126\/sciimmunol.abc9934","volume":"7","author":"X Wu","year":"2022","unstructured":"Wu X, Kasmani MY, Zheng S, Khatun A, Chen Y, Winkler W, Zander R, Burns R, Taparowsky EJ, Sun J et al (2022) BATF promotes group 2 innate lymphoid cell-mediated lung tissue protection during acute respiratory virus infection. Sci Immunol 7(67):eabc9934","journal-title":"Sci Immunol"},{"issue":"10","key":"2345_CR102","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s13238-017-0503-6","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Jiang J, Tien P, Liu W, Li J (2018) IFN-lambda: a new spotlight in innate immunity against influenza virus infection. Protein Cell 9(10):832\u2013837","journal-title":"Protein Cell"},{"issue":"9","key":"2345_CR103","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1128\/JVI.74.9.3996-4003.2000","volume":"74","author":"GE Price","year":"2000","unstructured":"Price GE, Gaszewska-Mastarlarz A, Moskophidis D (2000) The role of alpha\/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 74(9):3996\u20134003","journal-title":"J Virol"},{"issue":"3","key":"2345_CR104","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni1041","volume":"5","author":"ME Dahl","year":"2004","unstructured":"Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB (2004) Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 5(3):337\u2013343","journal-title":"Nat Immunol"},{"issue":"1","key":"2345_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201901-0214OC","volume":"201","author":"A Watson","year":"2020","unstructured":"Watson A, Spalluto CM, McCrae C, Cellura D, Burke H, Cunoosamy D, Freeman A, Hicks A, Huhn M, Ostridge K et al (2020) Dynamics of IFN-beta responses during respiratory viral infection. Insights for therapeutic strategies. Am J Respir Crit Care Med 201(1):83\u201394","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2345_CR106","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/ni.2535","volume":"14","author":"MS Lee","year":"2013","unstructured":"Lee MS, Kim B, Oh GT, Kim YJ (2013) OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol 14(4):346\u2013355","journal-title":"Nat Immunol"},{"issue":"1","key":"2345_CR107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4168\/aair.2022.14.1.99","volume":"14","author":"Y Chang","year":"2022","unstructured":"Chang Y, Kang JS, Jung K, Chung DH, Ha SJ, Kim YJ, Kim HY (2022) OASL1-mediated inhibition of type I IFN reduces influenza A infection-induced airway inflammation by regulating ILC2s. Allergy Asthma Immunol Res 14(1):99\u2013116","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"2345_CR108","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/mi.2017.41","volume":"11","author":"D Califano","year":"2018","unstructured":"Califano D, Furuya Y, Roberts S, Avram D, McKenzie ANJ, Metzger DW (2018) IFN-gamma increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells. Mucosal Immunol 11(1):209\u2013219","journal-title":"Mucosal Immunol"},{"issue":"8","key":"2345_CR109","doi-asserted-by":"publisher","first-page":"e2118535119","DOI":"10.1073\/pnas.2118535119","volume":"119","author":"TK Barman","year":"2022","unstructured":"Barman TK, Huber VC, Bonin JL, Califano D, Salmon SL, McKenzie ANJ, Metzger DW (2022) Viral PB1-F2 and host IFN-gamma guide ILC2 and T cell activity during influenza virus infection. Proc Natl Acad Sci USA 119(8):e2118535119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5923","key":"2345_CR110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.1165557","volume":"324","author":"AC Palmenberg","year":"2009","unstructured":"Palmenberg AC, Spiro D, Kuzmickas R, Wang S, Djikeng A, Rathe JA, Fraser-Liggett CM, Liggett SB (2009) Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324(5923):55\u201359","journal-title":"Science"},{"issue":"1","key":"2345_CR111","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1067\/mai.2003.33","volume":"111","author":"A Kotaniemi-Syrjanen","year":"2003","unstructured":"Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M (2003) Rhinovirus-induced wheezing in infancy\u2013the first sign of childhood asthma? J Allergy Clin Immunol 111(1):66\u201371","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2345_CR112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","volume":"178","author":"DJ Jackson","year":"2008","unstructured":"Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E et al (2008) Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178(7):667\u2013672","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2345_CR113","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/all.13723","volume":"74","author":"K Hasegawa","year":"2019","unstructured":"Hasegawa K, Hoptay CE, Harmon B, Celedon JC, Mansbach JM, Piedra PA, Freishtat RJ, Camargo CA Jr (2019) Association of type 2 cytokines in severe rhinovirus bronchiolitis during infancy with risk of developing asthma: a multicenter prospective study. Allergy 74(7):1374\u20131377","journal-title":"Allergy"},{"issue":"2","key":"2345_CR114","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jaci.2016.03.049","volume":"139","author":"FJ Rubner","year":"2017","unstructured":"Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, Gern JE, Lemanske RF Jr (2017) Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol 139(2):501\u2013507","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2345_CR115","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2014.04.020","volume":"134","author":"JY Hong","year":"2014","unstructured":"Hong JY, Bentley JK, Chung Y, Lei J, Steenrod JM, Chen Q, Sajjan US, Hershenson MB (2014) Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 134(2):429\u2013439","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2345_CR116","doi-asserted-by":"publisher","first-page":"L983","DOI":"10.1152\/ajplung.00368.2016","volume":"312","author":"C Rajput","year":"2017","unstructured":"Rajput C, Cui T, Han M, Lei J, Hinde JL, Wu Q, Bentley JK, Hershenson MB (2017) RORalpha-dependent type 2 innate lymphoid cells are required and sufficient for mucous metaplasia in immature mice. Am J Physiol Lung Cell Mol Physiol 312(6):L983\u2013L993","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"2345_CR117","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4049\/jimmunol.1700216","volume":"199","author":"M Han","year":"2017","unstructured":"Han M, Rajput C, Hong JY, Lei J, Hinde JL, Wu Q, Bentley JK, Hershenson MB (2017) The Innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol 199(4):1308\u20131318","journal-title":"J Immunol"},{"issue":"12","key":"2345_CR118","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","volume":"190","author":"DJ Jackson","year":"2014","unstructured":"Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Jerico D-R, Telcian AG, Nikonova A, Zhu J et al (2014) IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190(12):1373\u20131382","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2345_CR119","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1164\/rccm.202010-3754OC","volume":"204","author":"J Dhariwal","year":"2021","unstructured":"Dhariwal J, Cameron A, Wong E, Paulsen M, Trujillo-Torralbo MB, Del Rosario A, Bakhsoliani E, Kebadze T, Almond M, Farne H et al (2021) Pulmonary innate lymphoid cell responses during rhinovirus-induced asthma exacerbations in vivo: a clinical trial. Am J Respir Crit Care Med 204(11):1259\u20131273","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2345_CR120","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1165\/rcmb.2016-0056OC","volume":"56","author":"M Han","year":"2017","unstructured":"Han M, Hong JY, Jaipalli S, Rajput C, Lei J, Hinde JL, Chen Q, Hershenson NM, Bentley JK, Hershenson MB (2017) IFN-gamma blocks development of an asthma phenotype in rhinovirus-infected baby mice by inhibiting type 2 innate lymphoid cells. Am J Respir Cell Mol Biol 56(2):242\u2013251","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2345_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649520","volume":"12","author":"C Rajput","year":"2021","unstructured":"Rajput C, Han M, Ishikawa T, Lei J, Goldsmith AM, Jazaeri S, Stroupe CC, Bentley JK, Hershenson MB (2021) Rhinovirus C infection induces type 2 innate lymphoid cell expansion and eosinophilic airway inflammation. Front Immunol 12:649520","journal-title":"Front Immunol"},{"issue":"4","key":"2345_CR122","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1183\/09031936.00049214","volume":"44","author":"GF Perez","year":"2014","unstructured":"Perez GF, Pancham K, Huseni S, Preciado D, Freishtat RJ, Colberg-Poley AM, Hoffman EP, Rose MC, Nino G (2014) Rhinovirus infection in young children is associated with elevated airway TSLP levels. Eur Respir J 44(4):1075\u20131078","journal-title":"Eur Respir J"},{"issue":"1","key":"2345_CR123","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s42003-022-03367-z","volume":"5","author":"TC Williams","year":"2022","unstructured":"Williams TC, Loo SL, Nichol KS, Reid AT, Veerati PC, Esneau C, Wark PAB, Grainge CL, Knight DA, Vincent T et al (2022) IL-25 blockade augments antiviral immunity during respiratory virus infection. Commun Biol 5(1):415","journal-title":"Commun Biol"},{"issue":"14","key":"2345_CR124","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.7150\/ijbs.64762","volume":"17","author":"Z Shang","year":"2021","unstructured":"Shang Z, Tan S, Ma D (2021) Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies. Int J Biol Sci 17(14):4073\u20134091","journal-title":"Int J Biol Sci"},{"issue":"6","key":"2345_CR125","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13803","volume":"33","author":"GA Rossi","year":"2022","unstructured":"Rossi GA, Ballarini S, Salvati P, Sacco O, Colin AA (2022) Alarmins and innate lymphoid cells 2 activation: a common pathogenetic link connecting respiratory syncytial virus bronchiolitis and later wheezing\/asthma? Pediatr Allergy Immunol 33(6):e13803","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"2345_CR126","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/v12050521","volume":"12","author":"AE Norlander","year":"2020","unstructured":"Norlander AE, Peebles RS Jr (2020) Innate type 2 responses to respiratory syncytial virus infection. Viruses 12(5):521","journal-title":"Viruses"},{"issue":"11","key":"2345_CR127","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1164\/rccm.201812-2366OC","volume":"200","author":"LD Vu","year":"2019","unstructured":"Vu LD, Siefker D, Jones TL, You D, Taylor R, DeVincenzo J, Cormier SA (2019) Elevated levels of type 2 respiratory innate lymphoid cells in human infants with severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 200(11):1414\u20131423","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2345_CR128","doi-asserted-by":"publisher","first-page":"948","DOI":"10.4049\/jimmunol.1302007","volume":"192","author":"N Marr","year":"2014","unstructured":"Marr N, Wang TI, Kam SH, Hu YS, Sharma AA, Lam A, Markowski J, Solimano A, Lavoie PM, Turvey SE (2014) Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol 192(3):948\u2013957","journal-title":"J Immunol"},{"issue":"10","key":"2345_CR129","doi-asserted-by":"publisher","first-page":"e1005217","DOI":"10.1371\/journal.ppat.1005217","volume":"11","author":"J Saravia","year":"2015","unstructured":"Saravia J, You D, Shrestha B, Jaligama S, Siefker D, Lee GI, Harding JN, Jones TL, Rovnaghi C, Bagga B et al (2015) Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog 11(10):e1005217","journal-title":"PLoS Pathog"},{"issue":"5","key":"2345_CR130","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/icb.2012.9","volume":"90","author":"NA de Weerd","year":"2012","unstructured":"de Weerd NA, Nguyen T (2012) The interferons and their receptors\u2013distribution and regulation. Immunol Cell Biol 90(5):483\u2013491","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"2345_CR131","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4049\/jimmunol.1601984","volume":"199","author":"MT Stier","year":"2017","unstructured":"Stier MT, Goleniewska K, Cephus JY, Newcomb DC, Sherrill TP, Boyd KL, Bloodworth MH, Moore ML, Chen K, Kolls JK et al (2017) STAT1 represses cytokine-producing group 2 and group 3 innate lymphoid cells during viral infection. J Immunol 199(2):510\u2013519","journal-title":"J Immunol"},{"issue":"12","key":"2345_CR132","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/imt-2018-0059","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D, Bai S, Cui Y, Zhao N, Qi F, Liu J, Zeng S, Xu L, Hu H, Liu B (2018) Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33\/ST2 pathway. Immunotherapy 10(12):1065\u20131076","journal-title":"Immunotherapy"},{"key":"2345_CR133","doi-asserted-by":"publisher","first-page":"867022","DOI":"10.3389\/fimmu.2022.867022","volume":"13","author":"KH Antunes","year":"2022","unstructured":"Antunes KH, Cassao G, Santos LD, Borges SG, Poppe J, Goncalves JB, Nunes EDS, Recacho GF, Sousa VB, Da Silva GS et al (2022) Airway administration of bacterial lysate OM-85 protects mice against respiratory syncytial virus infection. Front Immunol 13:867022","journal-title":"Front Immunol"},{"issue":"12","key":"2345_CR134","doi-asserted-by":"publisher","first-page":"e1224","DOI":"10.1002\/cti2.1224","volume":"9","author":"M Garcia","year":"2020","unstructured":"Garcia M, Kokkinou E, Carrasco Garcia A, Parrot T, Palma Medina LM, Maleki KT, Christ W, Varnaite R, Filipovic I, Ljunggren HG et al (2020) Innate lymphoid cell composition associates with COVID-19 disease severity. Clin Transl Immunology 9(12):e1224","journal-title":"Clin Transl Immunology"},{"issue":"2","key":"2345_CR135","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41423-020-00596-2","volume":"18","author":"A Gomez-Cadena","year":"2021","unstructured":"Gomez-Cadena A, Spehner L, Kroemer M, Khelil MB, Bouiller K, Verdeil G, Trabanelli S, Borg C, Loyon R, Jandus C (2021) Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment. Cell Mol Immunol 18(2):484\u2013486","journal-title":"Cell Mol Immunol"},{"key":"2345_CR136","doi-asserted-by":"publisher","first-page":"e74681","DOI":"10.7554\/eLife.74681","volume":"11","author":"NJ Silverstein","year":"2022","unstructured":"Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, Boribong BP, Loiselle M, Davis J, Leonard MM, Kuri-Cervantes L et al (2022) Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection. Elife 11:e74681","journal-title":"Elife"},{"key":"2345_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.101008","volume":"80","author":"A Kumar","year":"2021","unstructured":"Kumar A, Cao W, Endrias K, Kuchipudi SV, Mittal SK, Sambhara S (2021) Innate lymphoid cells (ILC) in SARS-CoV-2 infection. Mol Aspects Med 80:101008","journal-title":"Mol Aspects Med"},{"issue":"12","key":"2345_CR138","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/eji.202149311","volume":"51","author":"AMC Gomes","year":"2021","unstructured":"Gomes AMC, Farias GB, Dias-Silva M, Laia J, Trombetta AC, Godinho-Santos A, Rosmaninho P, Santos DF, Conceicao CM, Costa-Reis R et al (2021) SARS-CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10. Eur J Immunol 51(12):3194\u20133201","journal-title":"Eur J Immunol"},{"issue":"6504","key":"2345_CR139","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Pere H, Charbit B, Bondet V, Chenevier-Gobeaux C et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504):718\u2013724","journal-title":"Science"},{"issue":"11","key":"2345_CR140","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","volume":"54","author":"B Kramer","year":"2021","unstructured":"Kramer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-Garcia R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J et al (2021) Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 54(11):2650\u20132669, e2614","journal-title":"Immunity"},{"issue":"6","key":"2345_CR141","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P et al (2016) IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17(6):636\u2013645","journal-title":"Nat Immunol"},{"issue":"6","key":"2345_CR142","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.3447","volume":"17","author":"Y Ohne","year":"2016","unstructured":"Ohne Y, Silver JS, Thompson-Snipes L, Collet MA, Blanck JP, Cantarel BL, Copenhaver AM, Humbles AA, Liu YJ (2016) IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol 17(6):646\u2013655","journal-title":"Nat Immunol"},{"issue":"6","key":"2345_CR143","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ni.3443","volume":"17","author":"JS Silver","year":"2016","unstructured":"Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R et al (2016) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17(6):626\u2013635","journal-title":"Nat Immunol"},{"issue":"11","key":"2345_CR144","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41577-022-00704-5","volume":"22","author":"H Spits","year":"2022","unstructured":"Spits H, Mjosberg J (2022) Heterogeneity of type 2 innate lymphoid cells. Nat Rev Immunol 22(11):701\u2013712","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02345-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T22:01:50Z","timestamp":1691100110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02345-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":144,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02345-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}